Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Eyenovia Inc
EYENCurrent price
1.44 USD
-0.04 USD (-2.70%)
Last closed
1.41 USD
Company
www.eyenovia.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
68 205 616 USD
Yield for 12 month
-30.10 %
1Y
3Y
5Y
10Y
15Y
EYEN
Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York. Address: 295 Madison Avenue, New York, NY, United States, 10017
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9 USDP/E ratio
–Dividend Yield
–Current Year
+3 787 USD
Last Year
+10 000 000 USD
Current Quarter
+4 993 USD
Last Quarter
+2 589 USD
Current Year
-783 208 USD
Last Year
-307 430 USD
Current Quarter
-331 460 USD
Last Quarter
-277 524 USD
Key Figures EYEN
1 year
3 years
5 years
10 years
EBITDA
-29 246 616 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-68.07 %
PEG Ratio
–
Return On Equity TTM
-368.02 %
Wall Street Target Price
9 USD
Revenue TTM
8 780 USD
Book Value
0.038 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
400 %
Dividend Yield
–
Gross Profit TTM
12 400 000 USD
Earnings per share
-0.74 USD
Diluted Eps TTM
-0.74 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics EYEN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EYEN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation EYEN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
4993.2763
Price Sales TTM
3988.1572
Enterprise Value EBITDA
-5.4127
Price Book MRQ
19.355
Financials EYEN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EYEN
For 52 weeks
0.5 USD
2.57 USD
50 Day MA
0.8 USD
Shares Short Prior Month
3 924 129
200 Day MA
1.27 USD
Short Ratio
6.15
Shares Short
3 928 275
Short Percent
8.21 %
BeatStart